Form 4: Kellogg W K Foundation Trust Sells 114,583 Shares of Kellanova

The Kellogg W K Foundation Trust sold 114,583 shares of Kellanova stock at a price of $81.4214 per share on January 14, 2025.

Summary

• The Kellogg W K Foundation Trust, a significant shareholder of Kellanova, sold 114,583 shares of common stock.
• The transaction occurred on January 14, 2025, at a price of $81.4214 per share.
• Following the sale, the Trust beneficially owns 48,534,944 shares of Kellanova.
• The sale was executed under a pre-arranged trading plan intended to comply with Rule 10b5-1(c) of the Securities Exchange Act of 1934.
• The W.K. Kellogg Foundation is the sole beneficiary of the Trust.

Sentiment

Score: 5

Explanation: The document reports a routine stock sale by a major shareholder under a pre-arranged plan, which is neither positive nor negative.

Management Comments

• The sales reported on this Form 4 were made pursuant to trading instructions given by the W.K. Kellogg Foundation Trust on May 7, 2024 that are intended to comply with Rule 10b5-1(c) under the Securities and Exchange Act of 1934.

Industry Context

This is a routine transaction for a major shareholder and does not indicate any specific trend in the industry.

Comparison to Industry Standards

• Sales by major shareholders are common and are often pre-planned under Rule 10b5-1 trading plans.
• The size of this sale is not unusual for a large institutional holder like the Kellogg W K Foundation Trust.
• Comparable transactions can be seen with other large institutional holders of publicly traded companies.

Stakeholder Impact

• The sale may have a minor impact on the stock price, but it is unlikely to be significant given the pre-planned nature of the transaction.

Key Dates

Keywords

Kellanova, Kellogg W K Foundation Trust, stock sale, Rule 10b5-1, shareholder, equity securities